You are here

Article info

Article menu
Epidemiology
BNT162b2 vaccine-induced humoral and cellular responses against SARS-CoV-2 variants in systemic lupus erythematosus

Authors

  • Quentin Moyon Inserm, Centre d’Immunologie et des Maladies Infectieuses (CIMI-Paris), Sorbonne Université, Paris, France Assistance Publique–Hôpitaux de Paris (AP-HP), Groupement Hospitalier Pitié–Salpêtrière (GHPS), French National Reference Center for Systemic Lupus Erythematosus, Antiphospholipid Antibody Syndrome and Other Autoimmune Disorders, Service de Médecine Interne 2, Institut E3M, Sorbonne Université, Paris, France PubMed articlesGoogle scholar articles
  • Delphine Sterlin Inserm, Centre d’Immunologie et des Maladies Infectieuses (CIMI-Paris), Sorbonne Université, Paris, France Assistance Publique Hôpitaux de Paris (AP-HP), Département d’Immunologie, Hôpital Pitié-Salpêtrière, Sorbonne Université, Paris, France PubMed articlesGoogle scholar articles
  • Makoto Miyara Inserm, Centre d’Immunologie et des Maladies Infectieuses (CIMI-Paris), Sorbonne Université, Paris, France Assistance Publique Hôpitaux de Paris (AP-HP), Département d’Immunologie, Hôpital Pitié-Salpêtrière, Sorbonne Université, Paris, France PubMed articlesGoogle scholar articles
  • François Anna Virology Department, Institut Pasteur-TheraVectys Joint Lab, Paris, France Unité de Virologie Moléculaire et Vaccinologie, Institut Pasteur, Paris, France PubMed articlesGoogle scholar articles
  • Alexis Mathian Inserm, Centre d’Immunologie et des Maladies Infectieuses (CIMI-Paris), Sorbonne Université, Paris, France Assistance Publique–Hôpitaux de Paris (AP-HP), Groupement Hospitalier Pitié–Salpêtrière (GHPS), French National Reference Center for Systemic Lupus Erythematosus, Antiphospholipid Antibody Syndrome and Other Autoimmune Disorders, Service de Médecine Interne 2, Institut E3M, Sorbonne Université, Paris, France PubMed articlesGoogle scholar articles
  • Raphael Lhote Inserm, Centre d’Immunologie et des Maladies Infectieuses (CIMI-Paris), Sorbonne Université, Paris, France Assistance Publique–Hôpitaux de Paris (AP-HP), Groupement Hospitalier Pitié–Salpêtrière (GHPS), French National Reference Center for Systemic Lupus Erythematosus, Antiphospholipid Antibody Syndrome and Other Autoimmune Disorders, Service de Médecine Interne 2, Institut E3M, Sorbonne Université, Paris, France PubMed articlesGoogle scholar articles
  • Pascale Ghillani-Dalbin Assistance Publique Hôpitaux de Paris (AP-HP), Département d’Immunologie, Hôpital Pitié-Salpêtrière, Sorbonne Université, Paris, France PubMed articlesGoogle scholar articles
  • Paul Breillat Inserm, Centre d’Immunologie et des Maladies Infectieuses (CIMI-Paris), Sorbonne Université, Paris, France PubMed articlesGoogle scholar articles
  • Sasi Mudumba Assay Development Department, Genalyte Inc, San Diego, California, USA PubMed articlesGoogle scholar articles
  • Sophia de Alba Assay Development Department, Genalyte Inc, San Diego, California, USA PubMed articlesGoogle scholar articles
  • Fleur Cohen-aubart Inserm, Centre d’Immunologie et des Maladies Infectieuses (CIMI-Paris), Sorbonne Université, Paris, France Assistance Publique–Hôpitaux de Paris (AP-HP), Groupement Hospitalier Pitié–Salpêtrière (GHPS), French National Reference Center for Systemic Lupus Erythematosus, Antiphospholipid Antibody Syndrome and Other Autoimmune Disorders, Service de Médecine Interne 2, Institut E3M, Sorbonne Université, Paris, France PubMed articlesGoogle scholar articles
  • Julien Haroche Inserm, Centre d’Immunologie et des Maladies Infectieuses (CIMI-Paris), Sorbonne Université, Paris, France Assistance Publique–Hôpitaux de Paris (AP-HP), Groupement Hospitalier Pitié–Salpêtrière (GHPS), French National Reference Center for Systemic Lupus Erythematosus, Antiphospholipid Antibody Syndrome and Other Autoimmune Disorders, Service de Médecine Interne 2, Institut E3M, Sorbonne Université, Paris, France PubMed articlesGoogle scholar articles
  • Micheline Pha Assistance Publique–Hôpitaux de Paris (AP-HP), Groupement Hospitalier Pitié–Salpêtrière (GHPS), French National Reference Center for Systemic Lupus Erythematosus, Antiphospholipid Antibody Syndrome and Other Autoimmune Disorders, Service de Médecine Interne 2, Institut E3M, Sorbonne Université, Paris, France PubMed articlesGoogle scholar articles
  • Thi Huong Du Boutin Assistance Publique–Hôpitaux de Paris (AP-HP), Groupement Hospitalier Pitié–Salpêtrière (GHPS), French National Reference Center for Systemic Lupus Erythematosus, Antiphospholipid Antibody Syndrome and Other Autoimmune Disorders, Service de Médecine Interne 2, Institut E3M, Sorbonne Université, Paris, France PubMed articlesGoogle scholar articles
  • Hedi Chaieb Assistance Publique–Hôpitaux de Paris (AP-HP), Groupement Hospitalier Pitié–Salpêtrière (GHPS), French National Reference Center for Systemic Lupus Erythematosus, Antiphospholipid Antibody Syndrome and Other Autoimmune Disorders, Service de Médecine Interne 2, Institut E3M, Sorbonne Université, Paris, France PubMed articlesGoogle scholar articles
  • Pedro Macedo Flores Assistance Publique–Hôpitaux de Paris (AP-HP), Groupement Hospitalier Pitié–Salpêtrière (GHPS), French National Reference Center for Systemic Lupus Erythematosus, Antiphospholipid Antibody Syndrome and Other Autoimmune Disorders, Service de Médecine Interne 2, Institut E3M, Sorbonne Université, Paris, France Mathématiques appliquées, Sorbonne Universite Faculte des Sciences et Ingenierie, Paris, France PubMed articlesGoogle scholar articles
  • Pierre Charneau Virology Department, Institut Pasteur-TheraVectys Joint Lab, Paris, France Unité de Virologie Moléculaire et Vaccinologie, Institut Pasteur, Paris, France PubMed articlesGoogle scholar articles
  • Guy Gorochov Inserm, Centre d’Immunologie et des Maladies Infectieuses (CIMI-Paris), Sorbonne Université, Paris, France Assistance Publique Hôpitaux de Paris (AP-HP), Département d’Immunologie, Hôpital Pitié-Salpêtrière, Sorbonne Université, Paris, France PubMed articlesGoogle scholar articles
  • Zahir Amoura Inserm, Centre d’Immunologie et des Maladies Infectieuses (CIMI-Paris), Sorbonne Université, Paris, France Assistance Publique–Hôpitaux de Paris (AP-HP), Groupement Hospitalier Pitié–Salpêtrière (GHPS), French National Reference Center for Systemic Lupus Erythematosus, Antiphospholipid Antibody Syndrome and Other Autoimmune Disorders, Service de Médecine Interne 2, Institut E3M, Sorbonne Université, Paris, France PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Zahir Amoura, Assistance Publique–Hôpitaux de Paris, Groupement Hospitalier Pitié–Salpêtrière, French National Reference Center for Systemic Lupus Erythematosus, Antiphospholipid Antibody Syndrome and Other Autoimmune Disorders, Service de Médecine Interne 2, Institut E3M, Sorbonne Université, Paris, 75006 Île-de-France, France; zahir.amoura{at}aphp.fr; Dr Guy Gorochov, Inserm, Centre d'Imunologie et des Maladies Infectieuses (Cimi-Paris), Assistance Publique Hôpitaux de Paris (AP-HP), Département d’Immunologie, Hôpital Pitié-Salpêtrière, Sorbonne Université, Paris, France; guy.gorochov{at}aphp.fr
View Full Text

Citation

Moyon Q, Sterlin D, Miyara M, et al
BNT162b2 vaccine-induced humoral and cellular responses against SARS-CoV-2 variants in systemic lupus erythematosus
Annals of the Rheumatic Diseases 2022;81:575-583.

Publication history

  • Received July 7, 2021
  • Accepted September 12, 2021
  • First published October 4, 2021.
Online issue publication 
March 10, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.